Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Venugopalareddy Mekala

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cancer Medicine|July 22, 2025
Integrative Analysis Reveals the Prognostic Effects of Epigenetic Regulators in Bladder CancerVenugopalareddy Mekala, Yupei Lin, Xiang Wang, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Gene signatures characterizing driver mutations in lung squamous carcinoma are predictive of the progression of pre-cancer lesionsYupei Lin, Venugopalareddy Mekala, Jianrong Li, et al.
International Journal of Cancer|December 16, 2025
Gene signatures characterizing driver mutations in lung squamous carcinoma are predictive of the progression of pre-cancer lesionsYupei Lin, Venugopalareddy Mekala, Jianrong Li, et al.
Scientific Reports|April 4, 2026
IL1R1 blockade augments CD40 agonist mediated immunity in pancreatic cancerAkash R Boda, Irfan N Bandey, Saikat Chowdhury, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cancer Medicine|July 22, 2025
Integrative Analysis Reveals the Prognostic Effects of Epigenetic Regulators in Bladder CancerVenugopalareddy Mekala, Yupei Lin, Xiang Wang, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Gene signatures characterizing driver mutations in lung squamous carcinoma are predictive of the progression of pre-cancer lesionsYupei Lin, Venugopalareddy Mekala, Jianrong Li, et al.
International Journal of Cancer|December 16, 2025
Gene signatures characterizing driver mutations in lung squamous carcinoma are predictive of the progression of pre-cancer lesionsYupei Lin, Venugopalareddy Mekala, Jianrong Li, et al.
Scientific Reports|April 4, 2026
IL1R1 blockade augments CD40 agonist mediated immunity in pancreatic cancerAkash R Boda, Irfan N Bandey, Saikat Chowdhury, et al.
Pageof 1